Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab in Real-Life Settings: The Prospective, REALITI-A Study

被引：0

作者：

Chaudhuri, R. ^{[1
]}

Canonica, G. W. ^{[2
]}

Bals, R. ^{[3
]}

Lougheed, M. D. ^{[4
]}

Pilette, C. ^{[5
,6
]}

Ramos-Barbon, D. ^{[7
]}

Pollard, S. ^{[8
]}

Maxwell, A. ^{[9
]}

Worsley, S. ^{[10
]}

Van Dyke, M. K. ^{[11
]}

Joksaite, S. ^{[12
]}

Howarth, P. ^{[13
]}

Cristancho, R. Alfonso ^{[14
]}

机构：

[1] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland

[2] Humanitas Res Hosp, Personalized Med Asthma & Allergy Clin, Milan, Italy

[3] Univ Klinikum Saarlandes Innere V, Homburg, Saarland, Germany

[4] Queens Univ, Kingston, ON, Canada

[5] UCLouvain, Clin Univ St Luc, Brussels, Belgium

[6] UCLouvain, Inst Expt & Clin Res, Brussels, Belgium

[7] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[8] Family Allergy & Asthma Res Inst, Louisville, KY USA

[9] GSK, Real World Study Delivery, Value Evidence & Outcomes, Global Med, Stevenage, Herts, England

[10] GSK, Real World Study Delivery, Uxbridge, Middx, England

[11] GSK, Epidemiol, Collegeville, PA USA

[12] GSK, R&D Projects Clin Platforms & Sci, Clin Stat, Uxbridge, Middx, England

[13] GSK House, Global Med, Brentford, England

[14] GSK, Value Evidence & Outcomes, Philadelphia, PA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4267

引用

页数：2